health
-
FDA Approves Eli Lilly Alzheimer’s Drug Kisunla Amid Safety Concerns
July 18, 2024 — infopulsetoday.com — The path to the FDA’s July 15 approval of donanemab was paved with controversy, clinical risk,…
-
FDA Approves Eli Lilly’s Donanemab for Early Symptomatic Alzheimer Disease
On July 15, 2024, the US Food and Drug Administration (FDA) approved donanemab, a monoclonal antibody developed by Eli Lilly and Company,…
-
Northwestern and Brigham Scientists Identify Immune Defect in Lupus and a Possible Way to Reverse It
On July 10, 2024, a joint research team from Northwestern University Feinberg School of Medicine and Harvard Medical School released a study…
-
UK E. coli Outbreak Linked to Supermarket Sandwiches Kills One, 275 Cases Confirmed
A fatal E. coli outbreak in the United Kingdom has resulted in one death and 67 hospitalizations as of June 27, 2024.…
-
Grail spin-out from Illumina completed June 2024 after EU regulatory order
June 29, 2024 — cyberinktimes.com — On June 24, 2024, a significant development occurred in the biotechnology sector as GRAIL, Inc., a…
-
FDA Approves Imetelstat for Treating Myelodysplastic Syndromes with Anemia
In a pivotal shift for the cancer treatment landscape, the US Food and Drug Administration (FDA) granted approval on June 15, 2024,…
-
Moderna’s KRAS Cancer Vaccine Candidate Was Dropped by Merck After Phase 1 Enrollment
In the realm of cancer research, the tetravalent vaccine candidate, code-named V941 or mRNA-5671, developed by Moderna, continues to garner attention within…
-
More Than 320 US Drugs Went Short in 2024, and Many Shortages Lasted Years
The scope of the 2024 drug shortage in the United States extends far beyond a simple inventory problem, now affecting over 300…
-
American Headache Society Endorses CGRP Antagonists for Migraines
On March 11, 2024, the American Headache Society issued a statement that underscores the evolving landscape of migraine treatment, highlighting the emergence…
-
Eight Children Die and 78 Hospitalized After Eating Sea Turtle Meat on Zanzibar Island
A laboratory analysis has determined that chelonitoxism was responsible for the deaths of nine residents of Zanzibar after they ate sea‑turtle meat,…
-
Noland Arbaugh Becomes First Human Recipient Of Neuralink Brain Implant
On January 15, 2024, a significant milestone was achieved in the field of health and technology as Noland Arbaugh, an American man…
-
Dengue Outbreak Surpasses 13 Million Cases in Americas
The 2024 dengue outbreak in Latin America and the Caribbean has reached a critical point, with the number of reported infections surpassing…
-
Dengue Spreads Across Central America as Guatemala and Panama Report the Most Deaths
Health authorities in Latin America and the Caribbean are confronting an unprecedented dengue crisis, with 13 million suspected infections reported as of…
-
CGRP Drugs and a Wearable Device Give Migraine Patients New Treatment Options
Migraine attacks often strike without warning, bringing intense pain, light sensitivity and nausea. Traditional acute treatments have been limited, and preventive regimens…
-
Fatty Liver Disease Gets a New Name as MASLD Replaces NAFLD in Global Liver Societies’ Consensus
Under a novel nomenclature agreed upon by three prominent global liver organizations, a prevalent liver ailment is set to undergo a significant…
-
Mali Reports 21 Deaths, 600 Cases in Dengue Fever Surge
Health authorities in Mali have recorded a sharp increase in dengue fever cases as of December 6, 2023, with at least 21…
-
Ghanaian Physician Wins Award for Expanding Abortion Access in Africa
On 29 November 2023, Eunice Brookman‑Amissah stepped onto a stage in Stockholm to receive the Right Livelihood Award, a prize often described…
-
FDA Approves Lung Cancer Drug Augtyro for ROS1-Positive Tumors, Trial Shows Responses
The U.S. Food and Drug Administration granted approval on November 15, 2023, for Repotrectinib, marketed as Augtyro, to treat a defined group…
-
AbbVie to Acquire ImmunoGen for $10.1 Billion, Adding Ovarian Cancer Drug Elahere
On a Wednesday in mid-November, AbbVie decided it would pay $10.1 billion for ImmunoGen. That is a lot of money for a…
-
FDA Grants Accelerated Approval to Talquetamab, a T-Cell Engager for Myeloma
For patients with multiple myeloma who have run out of options, August 15, 2023, changed the calculus. That day, regulators in the…
-
Talquetamab Wins FDA Accelerated Approval, Then European Approval, for Relapsed Multiple Myeloma
United States, August 16, 2023 — cybernewschronicle.com — On August 15, 2023, the medical community marked a significant milestone with the approval…
-
City of Hope Drug AOH1996 Moves Through Early Human Trial After Mouse Study Results
An investigational cancer medication called AOH1996 has entered Phase I clinical trials at City of Hope as of August 15, 2023, marking…
-
FDA Grants Accelerated Approval to Elrexfio for Heavily Treated Multiple Myeloma
/ HTML. So we need headings maybe and paragraphs . Must not add any extra info. Must keep facts: FDA approved Elranatamab…
-
South African variant: Beta strain B.1.351 impact on COVID-19 immunity
The South African variant refers to several variants of SARS-CoV-2, a virus that has been closely monitored globally due to its potential…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992